Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report)’s share price traded down 1.6% on Thursday . The stock traded as low as C$1.23 and last traded at C$1.23. 2,500 shares were traded during trading, a decline of 95% from the average session volume of 54,721 shares. The stock had previously closed at C$1.25.
Genscript Biotech Price Performance
The business has a 50-day moving average price of C$1.37 and a 200-day moving average price of C$1.38.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Recommended Stories
- Five stocks we like better than Genscript Biotech
- About the Markup Calculator
- Top 3 Investment Themes to Watch for in 2025
- How to trade using analyst ratings
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Consumer Staples Stocks, Explained
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
